Kaliumklorid-Glukose Sad

Potassium chloride and glucose monohydrate, the active ingredient in Kaliumklorid-Glukose Sad, is an electrolyte solution presented as an intravenous solution for intravenous use. It treats hypokalemia, supports fluid replacement and addresses hypoglycemia in hospitalized patients.

GNH USA supplies Kaliumklorid-Glukose Sad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kaliumklorid-Glukose Sad is used in fluid and electrolyte therapy to correct electrolyte imbalances and support metabolic needs.

- Hypokalemia: restores potassium levels to prevent cardiac and muscular complications. - Fluid replacement: provides isotonic fluid to maintain intravascular volume in dehydration or postoperative states. - Hypoglycemia: supplies glucose to raise blood sugar and facilitate cellular energy while aiding potassium uptake.

Kaliumklorid-Glukose Sad may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Nausea: transient feeling of sickness. - Hyperglycemia: elevated blood glucose levels, especially in diabetic patients.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm due to rapid potassium shifts. - Anaphylactic reaction: severe allergic response requiring immediate treatment. - Severe hyperkalemia: dangerous rise in potassium causing muscle weakness or cardiac arrest.

When using Kaliumklorid-Glukose Sad, clinicians should observe several precautions to ensure patient safety.

- Renal impairment: monitor serum potassium and adjust infusion rate. - Cardiac disease: assess ECG before and during therapy. - Diabetes mellitus: watch blood glucose levels closely. - Concomitant potassium‑sparing drugs: avoid additive hyperkalemia risk. - Pediatric use: dose must be calculated carefully by the prescriber. - Store at ambient temperature: keep in original container, protect from light and moisture.

Kaliumklorid-Glukose Sad can interact with other medications, influencing potassium or glucose balance.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may potentiate hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of severe hyperkalemia. - Insulin therapy: concurrent high‑dose insulin can cause rapid intracellular potassium shift.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt insulin‑mediated potassium uptake. - Digoxin: elevated potassium can enhance digoxin toxicity. - Loop diuretics: may cause fluctuating potassium levels requiring monitoring.